Hacettepe University

Hacettepe University

Hacettepe University
Sihhiye
06100 Ankara
Turkey
www.hacettepe.edu.tr

 

Lead Investigator

Prof. Turgay Dalkara

Professor of Neurology, MD, PhD Turgay Dalkara
Chair; Institute of Neurological Sciences and Psychiatry, Hacettepe University
+90 312-3051809
+90 312-3093451
Contact

Project Staff

Associate Professor of Neurology, MD Mehmet AKif Topcuoglu
Director ; Neurointensive Care Unit, Department of Neurology, Hacettepe University
+90 312-3051809
+90 312-3093451
Contact

Associate Professor of Neurology, MD Ethem Murat Arsava
Co-director; Neurointensive Care Unit, Department of Neurology, Hacettepe University
+90 312-3051809
+90 312-3093451
Contact
kittel(at)neuro.mpg.de

Stroke Fellow, MD Demet Funda Bas
Fellow; Neurointensive Care Unit, Department of Neurology, Hacettepe University
+90-312-3051809
+90-312-3093451
Contact

Institute Presentation

Hacettepe Univesity Hospital is one of the oldest and largest hospitals located in the capital city of Turkey, Ankara, and functions as a tertiary care center receiving direct admissions via the emergency medical transfer services and referrals from other hospitals within Ankara and neighboring cities in central Turkey. The Department of Neurology at Hacettepe Univesity Hospitals has extensive experience in the field of cerebrovascular diseases, and provides both inpatient and outpatient services for stroke patients. In addition, the department harbors a 9-bed neurointensive care unit, which provides state-of-the-art treatments for neurological critical care patients, including acute stroke patients. Imaging facilities including computed tomography, magnetic resonance imaging, transcranial and carotid-vertebral Doppler ultrasound are available 24/7 in the hospital, together with on-call stroke and neurointerventional radiology teams. In addition the department has participated in multiple acute stroke and secondary stroke prevention trials, including Potassium-channel Opening Stroke Trial (POST), PREvention of VTE after Acute Ischemic Stroke with LMWH or Enoxaparin (PREVAIL), and Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack (PERFORM). The center was the national coordinator in the PERFORM trial.

TOP